High drug prices are not justified by industry's spending on research and development
BMJ
.
2023 Feb 15:380:e071710.
doi: 10.1136/bmj-2022-071710.
Authors
Aris Angelis
1
2
,
Roman Polyakov
2
,
Olivier J Wouters
2
,
Els Torreele
3
,
Martin McKee
4
Affiliations
1
Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK
[email protected]
.
2
Department of Health Policy, London School of Economics and Political Science, London, UK.
3
Institute for Innovation and Public Purpose, University College London, London, UK.
4
Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
PMID:
36792119
DOI:
10.1136/bmj-2022-071710
No abstract available
MeSH terms
Drug Industry*
Humans
Research*